Buspirone regulates cortico-striatal gamma oscillations to ameliorate dyskinesia
Background Levodopa-induced dyskinesia (LID) in Parkinson's disease (PD) is linked to exaggerated gamma oscillations. Buspirone, a 5-HT1A receptor agonist, is a potent medication for psychiatric conditions, predominantly prescribed for anxiety treatment. Objective This study aims to investigate whet...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publishing
2025-12-01
|
| Edice: | Journal of Parkinson’s Disease |
| On-line přístup: | https://doi.org/10.1177/1877718X251380196 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|